We also tested tumors diagnosed as recurrent to the expression levels of both proteins and found that all recurrent cases showed moderate and strong sFRP3 expression, while DVL3 was moderately expressed in 78% of recurrent glioblastoma. Here, FRZB is linked to glioblastoma.